文献速递胸部肿瘤

间皮瘤的免疫微环境、全基因组拷贝数畸变与生存

The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma.
PubMed 文献 · J Thorac Oncol · 2017-02-28

研究在329例恶性胸膜间皮瘤患者中评估PD-L1表达、免疫浸润与全基因组拷贝数状态。PD-L1阳性见于41.7%(130/311),高表达仅9.6%(30/311),与非遗表型及免疫浸润相关;高PD-L1单因素与更差预后相关(HR=2.37,95%CI 1.57-3.56,p<0.001),多因素分析未达显著。基因组改变比例更高与上皮样亚型及更差生存相关(HR=1.59,95%CI 1.01-2.5,p=0.04)。

要点

  • PD-L1阳性(≥5%膜染色)见于41.7%(130/311),高表达(≥50%)仅9.6%(30/311)。
  • 高PD-L1表达单因素与更差预后相关(HR=2.37,95%CI 1.57-3.56,p<0.001),多因素分析未达显著。
  • 基因组改变比例更高与上皮样亚型及更差生存相关(HR=1.59,95%CI 1.01-2.5,p=0.04)。

核心结论

  • PD-L1表达与非上皮样恶性胸膜间皮瘤、较差临床结局及免疫浸润增加相关。
  • 基因组不稳定增加与PD-L1表达无关,但与更差生存相关。

研究设计与样本

  • 构建组织微阵列并采用PD-L1(克隆E1L3N)、CD4、CD8及FOXP3抗体染色。
  • PD-L1阳性定义为至少5%膜染色 regardless of intensity,高PD-L1阳性定义为至少50%。
  • 对113例代表性患者子集进行全基因组拷贝数分析,计算基因组改变百分比作为基因组不稳定性的替代指标。
  • 共评估329例患者,PD-L1可评估311例。

主要发现

  • PD-L1阳性见于130/311(41.7%),高PD-L1阳性仅30/311(9.6%)。
  • PD-L1阳性与非上皮样组织学亚型及CD4阳性、CD8阳性、FOXP3阳性淋巴细胞浸润增加相关。
  • 高PD-L1阳性表达单因素分析与更差预后相关(HR=2.37,95%CI 1.57-3.56,p<0.001),多因素分析未达显著。
  • 更高的基因组改变百分比与上皮样组织学亚型及更差生存相关(HR=1.59,95%CI 1.01-2.5,p=0.04),但与PD-L1表达无关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Results of recent clinical studies of immune checkpoint inhibitors in malignant pleural mesothelioma (MPM) have dampened initial enthusiasm. However, the immune environment and targets of these treatments such as programmed cell death protein 1 and its ligand programmed death ligand 1 (PD-L1) have not been well characterized in MPM. Using a large cohort of patients, we investigated PD-L1 expression, immune infiltrates, and genome-wide copy number status and correlated them to clinicopathological features. METHODS: Tissue microarrays were constructed and stained with PD-L1(clone E1L3N [Cell Signaling Technology, Danvers, MA]), cluster of differentiation 4, cluster of differentiation 8, and forkhead box P3 antibodies. PD-L1 positivity was defined as at least 5% membranous staining regardless of intensity, and high PD-L1 positivity was defined as at least 50%. Genomic DNA from a representative subset of 113 patients was used for genome-wide copy number analysis. The percent genome alteration was computed as a proxy for genomic instability, and statistical analyses were used to relate copy number aberrations to other variables. RESULTS: Among 329 patients evaluated, PD-L1 positivity was detected in 130 of 311 (41.7%), but high PD-L1 positivity was seen in only 30 of 311 (9.6%). PD-L1 positivity correlated with nonepithelioid histological subtype and increased infiltration with cluster of differentiation 4-positive, cluster of differentiation 8-positive, and forkhead box P3-positive lymphocytes. High PD-L1-positive expression correlated with worse prognosis (hazard ratio = 2.37, 95% confidence interval: 1.57-3.56, p < 0.001) in univariate analysis but not in multivariate analysis. Higher percent genome alteration was associated with epithelioid histological subtype and poorer survival (hazard ratio = 1.59, 95% confidence interval: 1.01-2.5, p = 0.04) but not PD-L1 expression. CONCLUSIONS: PD-L1 expression was associated with nonepithelioid MPM, poor clinical outcome, and increased immunological infiltrates. Increased genomic instability did not correlate with PD-L1 expression but was associated with poorer survival.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Thapa B, Salcedo A, Lin X, et al. The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma. J Thorac Oncol. 2017. PMID: 28257959. doi:10.1016/j.jtho.2017.02.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。